You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Novel Inhibitors of Pim Protein Kinases

    SBC: VORTEX BIOTECHNOLOGY CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): There is a growing body of evidence that implicates the protein kinase Pim-1 as a major driver of prostate cancer progression, and perhaps response to chemotherapy. Pim-1 is overexpressed in early prostate intraepithelial neoplasia and metastatic prostate cancer, and its levels predict response to therapy. Pim-1-overexpressing mouse prostate stem cells demonstr ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  2. Single molecule fluorescence detection of fragile X mutations

    SBC: AMBION DIAGNOSTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Fragile X Syndrome (FXS), is the most common form of inherited mental retardation, affecting 1 in 4000 males and about 1 in 6000 females of all ethnicities. Additionally, carrier frequencies are quite high. About 1 in 250 females carry Fragile X and about 1 in 800 men carry Fragile X. FXS was one of the first human diseases to be linked to an expansion of trip ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  3. Tooth Phone Auditory Device TPAD

    SBC: Audiodontics LLC            Topic: N/A

    DESCRIPTION (provided by applicant): TOPIC - Tooth Phone(R) Auditory Device - TPAD ABSTRACT The Tooth Phone(R) Auditory Device - TPAD is new alternative device to the only direct bone conduction hearing aid currently accepted by the Food and Drug Administration (FDA) for the treatment of certain specific types of hearing loss. Unlike the precedent FDA approved device that uses an osseointegrated i ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Acid Ceramidase, Target for Cancer

    SBC: Sphingogene, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): Acid ceramidase (AC) has been implicated as a novel target for cancer therapy because of its pivotal role in regulating interconversion of three key bioactive lipids; ceramide (Cer), sphingosine (Sph) and Sphingosine-1-Phosphate (S1P). It is well known that Cer functions predominantly as a tumor suppressor lipid and mediator of apoptosis following chemo and rad ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Bright White Tandem OLED with Carbon Nanotube Hole Injecting Interlayer

    SBC: SOLARNO INC            Topic: 10d

    White organic light emitting diodes (OLEDs) have become well recognized as an important candidate for future lighting products. However, outstanding challenges with respect to efficiency and degradation processes remain. Previous work on tandem OLED technology has produced devices with increased, brightness, efficiency, and lifetime. However, it was found that the interconnecting layer is cruci ...

    STTR Phase I 2009 Department of Energy
  6. Therapeutic Effectiveness of T Cell Receptor mimic (TCRm) Antibodies in Breast Ca

    SBC: RECEPTOR LOGIC, LTD            Topic: N/A

    DESCRIPTION (provided by applicant): The American Cancer Society announces annually the staggering number of women that are diagnosed with and die from invasive breast cancer in the United States. As with all cancers, treatment success rates are higher in early stages and treatment options vary with disease progression. Despite considerable focus on curing or ameliorating this disease, there are ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  7. New chaperones for folding and assembly of proteins

    SBC: FIDELITY SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A novel approach is needed to overcome the deficiencies of protein production technology and ensure the produced enzymes fold into physiologically effective three-dimensional conformations. We discovered that incorporation of novel archaeal chaperones into a host-vector system and into in vitro enzymatic reactions helps both to recover proteins from inclusion b ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. Advanced Software for Enabling Quantitative 3D Stress Echocardiography

    SBC: IGI TECHNOLOGIES, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Through more than 5 years of research, we have developed a new cardiovascular procedure termed quantitative three-dimensional (3D) stress echocardiography (echo). Because of exceedingly high computational demands, the procedure remains clinically nonviable despite our mature academic research. The objective of this STTR project is to remove the computation bott ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Long Read Next Generation Sequencing Technology Development

    SBC: LC Sciences, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal is to develop a high-throughput, long-read, accurate, fast, and low-cost sequencing method. As the recent next generation sequencing pours out DNA/RNA sequence information at an unprecedented rate, it is becoming apparent that fundamentally these cyclic sequencing methods are unlikely to either reach the long read or produce the accuracy to match ...

    STTR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  10. 3-D Nanofilm Asymmetric Ultracapacitor

    SBC: Ionova Technologies, Inc.            Topic: 15b

    Asymmetric ultracapacitors achieve greater energy density versus today¿s Electric Double Layer Capacitors (EDLC) by utilizing one activated carbon EDLC electrode and one insertion (battery-like) electrode. Asymmetric ultracapacitors based on non-aqueous electrolytes provide improvements in energy density but they provide no improvement in cost, safety or in environmental impact. Alternatively, aq ...

    STTR Phase I 2009 Department of Energy
US Flag An Official Website of the United States Government